A nurse in a long-term care facility is collecting data from a client who has a new prescription for glyburide. The client reports feeling anxious and having profuse sweating. Which of the following findings should the nurse expect?

The correct answer is D: Decreased blood glucose level. Glyburide is a sulfonylurea used to treat diabetes by stimulating insulin release, which can lead to hypoglycemia. Anxiety and sweating are common symptoms of hypoglycemia. Chvostek's sign (choice A) is associated with hypocalcemia, not hypoglycemia. Pitting pedal edema (choice B) is a sign of fluid retention and not related to glyburide use. Decreased deep-tendon reflexes (choice C) are not typically associated with glyburide.